The U.S. Patent and Trademark Office ruled Monday that patents for some CRISPR gene-editing technologies don’t belong to the University of California. CRISpr technologies were first developed in 2012 by Jennifer Doudna of UC Berkeley and Emmanuelle Charpentier of University of Vienna. The potentially lucrative technology is being tested to help cure genetic diseases and abnormalities. The ruling leaves UC Berkeley with more than 40 other patents related to the technology, according to a UC Berkeley professor. Some, however, argue that the technology should not be patented at all, including a member of the lab who chose to remain anonymous for fear of retribution, says a researcher who was involved in the CVC legal team. The decision complicates the work of biotech companies . . .
Read more at www.dailycal.org